Cohance Lifesciences Limited
COHANCE
Rangering i aksjer
#6383
Headquartered in Hyderabad, Cohance Lifesciences Limited operates as a... Headquartered in Hyderabad, Cohance Lifesciences Limited operates as a pharmaceutical enterprise, with primary expertise in contract development and manufacturing (CDMO) services. Its business scope also includes the creation of active pharmaceutical ingredients (APIs) and diverse specialty chemicals. The company, previously known as Suven Pharmaceuticals Limited, underwent a corporate rebranding following its amalgamation with Cohance Lifesciences, a transition officially effective May 1, 2025.
Aksjekurs
$5.05
Sist synkronisert: 2026-10-19
Markedsverdi
$1.93B
Endring (1 dag)
-1.44%
Endring (1 år)
-57.38%
Land
IN
Handel Cohance Lifesciences Limited (COHANCE)
Kategori
Healthcare
EPS for Cohance Lifesciences Limited (COHANCE)
EPS per June 2025 TTM: $0.11
Ifølge de siste økonomiske rapportene og aksjekursen til Cohance Lifesciences Limited er selskapets nåværende EPS (TTM) $0.11. Ved slutten av 2024 hadde selskapet en EPS på $0.14, en nedgang sammenlignet med EPS-en i 2023 som var $0.20.
EPS-historikk for Cohance Lifesciences Limited fra 2019 til 2026
EPS ved slutten av hvert år
| År | EPS | Endre |
|---|---|---|
| 2026 (TTM) | $0.11 | -9.42% |
| 2025 | $0.12 | -13.07% |
| 2024 | $0.14 | -28.03% |
| 2023 | $0.20 | -16.30% |
| 2022 | $0.23 | 20.83% |
| 2021 | $0.19 | 17.60% |
| 2020 | $0.17 | 167.48% |
| 2019 | $0.06 | 0.00% |
EPS for lignende selskaper eller konkurrenter
| Selskap | EPS | EPS-forskjell | Land |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $0.56 | 411.78% |
IN
|
